Open AccessAssessment of total sialic acid and lipid-bound sialic acid in management of brain tumors
Author(s) -
Manjula Shantaram,
Anjali Rao,
Annaya Rao Aroor,
A. Raja,
Suryanrayana Rao,
Flama Monteiro
Publication year - 2009
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.56315
Subject(s) - glycoconjugate , sialic acid , medicine , brain tumor , medulloblastoma , cerebrospinal fluid , pathology , glioma , cancer research , biochemistry , biology
Glycoconjugate molecules expressed at the plasma membrane of mammalian cells have been reported to be associated with tumor progression. The measurement of total sialic acid (TSA) and lipid-bound sialic acid (LBSA) in the cerebrospinal fluid (CSF) is suggested to be useful for the diagnosis of brain tumors. But there are very few reports available on the serum glycoconjugate levels in patients with brain tumors.